Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mitralign Percutaneous Annuloplasty First in Man (FIM) Study

NCT01852149 is registered in ClinicalTrials.gov with Mitralign, Inc. as lead sponsor.

NCT NCT01852149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01852149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mitralign Percutaneous Annuloplasty First in Man (FIM) Study
Lead sponsor
Mitralign, Inc.
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2009
Completion date
September 30, 2015
Enrollment
35 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

functional mitral regurgitation